Equine Behavior Problems—Around Farriery: Foot Pain in 11 Horses

Although foot pain may clearly be the cause when a horse with foot pathology does not tolerate farriery, it may be overlooked or underappreciated as the cause of this behavioral problem when the pathology is mild and/or chronic. In this study, the records of 11 adult horses whose behavior for farriery initially warranted sedation for trimming and shoeing were reviewed. All 11 horses had a history of chronic lameness that was mild to moderate, but foot pain was the presenting complaint in only seven horses - all with chronic laminitis. The other four horses had abnormal foot conformation (long-toe, low-heel, or “club foot), but the lameness had not been attributed to the foot. All 11 horses showed improvement in gait with corrective trimming and shoeing. In each case, sedation for farriery could be discontinued after one to six visits, concurrent with the improvements in gait and foot pathology. On the basis of the survey results from 17 professional farriers, an ethogram of farriery-related undesirable horse behavior was developed.     

Recovery Quality After Romifidine Versus Detomidine Infusion During Isoflurane Anesthesia in Horses

To examine the influence of detomidine or romifidine on recovery quality from isoflurane anesthesia, 78 anesthetic records were reviewed, from horses that had received romifidine (group R) during premedication [80–120 μg kg⁻¹ IV], anesthetic maintenance (40 μg kg⁻¹ hour⁻¹ IV), and recovery (20 μg kg⁻¹ IV) or detomidine (group D), at doses of 10–20 μg kg⁻¹ IV, 5 μg kg⁻¹ hour⁻¹ IV, and 2.5 μg kg⁻¹ IV, respectively. Duration of the different recovery phases, the number of attempts to sternal and standing, scores for transition to standing (TrSta), balance and coordination once standing (BC), and final recovery score (FS) were compared between groups using a Mann–Whitney U-test, independent t-test, or chi-squared test, as appropriate (alpha 0.05). Parametric data are represented as the mean ± standard deviation, and nonparametric data as the median (interquartile range). Compared with group D (25 horses), horses in group R (53 horses) needed significantly fewer attempts to achieve sternal recumbency [R 1 (1–1) vs. D 1 (1–2)], remained significantly longer in sternal recumbency [R 10 (3–14,5) vs. D 5 (1–9,5) minutes], needed significantly less attempts to stand [R 1 (1–1) vs. D 2 (1–4)], and a significantly shorter time to stand after making their first attempt [R 0 (0–0) vs. D 3 (0–6) minutes], with significantly better scores for TrSta, BC, and FS in group R. The results suggest that, at the doses used, romifidine provides a better recovery quality.     

Long Toes in the Hind Feet and Pain in the Gluteal Region: An Observational Study of 77 Horses

This study deals with the relationship between long toes in the hind feet and pain in the gluteal region in horses, and the remedial value of trimming/shoeing that moves the breakover point back at the toe. Seventy seven client-owned horses were studied, 67 shod riding horses retrospectively and 10 barefoot broodmares prospectively. The 10 mares were evaluated twice, and 24 of the 67 riding horses were re-evaluated at the next shoeing, for a total of 111 observations. Each horse underwent gluteal palpation and lateral radiographs of both hind feet. Toe length was quantified as breakover distance (BD), the horizontal distance between the tip of the third phalanx and the dorsalmost point at which the wall/shoe was in contact with the ground. The BD was then shortened with trimming +/− shoeing to a length of ≤15mm (shod horses) or ≤20 mm (barefoot horses). The 24 riding horses were re-evaluated 4-6 weeks later and the 10 broodmares 1 week after trimming.     

Comparison of the Sedative and Hemodynamic Effects of Acepromazine and Promethazine in the Standing Horse

The objective of this study was to compare the sedative and peripheral hemodynamic effects of acepromazine (ACP) and promethazine (PTZ) in the standing healthy horse. Nine healthy Warmblood horses randomly received either intravenous ACP at 0.1 mg/kg or PTZ at 0.1, 0.2, and 0.3 mg/kg. A sedation score based on clinical examination was recorded, and systolic arterial blood pressure was noninvasively evaluated using a Doppler flow detector at the tail, just before and every 15 minutes until 60 minutes after drug injection. Hemodynamics of the median artery of the left forelimb was studied using Doppler ultrasonography just before and 45 minutes after injection of the drug, which allowed calculation of surface (SURF), diameter (DIAM), and circumference (CIRC) of the vessel and peak systolic velocity (PSV), end diastolic velocity (EDV), mean velocity (MV), volumetric flow (VF), and resistivity index (RI) of the blood flow. Regardless of the dose used, PTZ had lesser sedative and hypotensive effects than ACP at 0.1 mg/kg and did not induce significant variations in SURF, DIAM, CIRC, PSV, EDV, MV, VF, and RI of the studied standing horses. Conversely, the vasodilatory properties of ACP were illustrated by a significant increase in SURF, DIAM, CIRC, PSV, EDV, MV, and VF and a significant reduction of the RI. Unlike ACP, PTZ did not induce alterations on the morphology of the Doppler waveform. PTZ appears to have less sedative and peripheral vasodilator effects than ACP, thus it could be safer than ACP in patients suffering from hypotension.     

Peritoneal Lavage and Drainage with Fenestrated Balloon Catheters in Standing Horses: A Comparative Study

This experimental study compares the efficiency of two fenestrated balloon catheters in allowing drainage of fluid during abdominal lavage in 12 healthy horses. Catheter A (with multiple side holes) or catheter B (with a single side hole) was placed in the ventral abdominal wall. Lactated Ringer's solution was instilled through a catheter in each paralumbar fossa of the standing horse. Drainage was performed through two catheters A in group 1, one catheter A in group 2, and one catheter B in group 3. Drainage was not significantly faster when using two, as compared with one, catheters A (P = 1). Amount of fluids recovered was greater using catheter A compared with catheter B (P = .004). Abdominal fluid analysis on day 30 was significantly higher (P = .008) for total protein in individuals with catheter B compared with catheter A. Use of one multiple fenestrated balloon catheter may be justified in clinical cases that need abdominal lavage and drainage.     

Pharmacokinetics and Effects of Alkalization after Intravenous Administration of Eltenac in Horses

Eltenac (ELT) [4-(2,6-dichlorophenyl)amino-3-thiophene] is a non-steroidal anti-inflammatory drug (NSAID) that was developed for veterinary use in horses and cattle. The pharmacokinetics of ELT was evaluated in horses at 0.5 mg/kg body weight (BW) after single IV injection after 5 days of repeated IV administration and after a single IV injection in horses previously subjected to 250 mg/kg BW of sodium bicarbonate (NaHCO₃) as an alkalization treatment. The aim was to determine whether blood and subsequent urinary alkalization could modify the pharmacokinetics of ELT. Drug quantification was performed with serum and urine using high performance liquid chromatography with UV-visible detection. The results were also integrated with cyclo-oxygenase-inhibition literature data to review the dosage scheme of ELT in horses. After a single intravenous administration, ELT was characterized by rapid distribution (mean t½_λ1 = 0.18 ± 0.07 hour) and a short elimination half-life (mean t½_λ2 = 2.9 ± 0.68 hour). The volume of distribution was small (V_dss = 253.51 ± 47.55 mL/kg), which is likely because of the high percentage of drug protein binding (approximately 97%). The AUC_0-∞ and Cl_B were 6.92 ± 0.84 h*μg/mL and 73.2 ± 10 mL/h/kg, respectively. Repeated administration did not cause either accumulation or modification of the pharmacokinetic profile. The in vitro effective concentrations were maintained for a 6-hour period. The alkalization procedure appeared to accelerate drug elimination, as ELT was quantifiable only for 6 hours; however, the drug clearance was not significantly modified. Thus, the administration of alkaline compounds to accelerate the elimination of ELT is not completely confirmed.     

A Technique for Examining the External Ear Canal in Standing Sedated Horses

In this study ultrasonography, local anesthesia, and endoscopy were performed in both ears of 23 horses. The aim was to find a reliable technique for examination of the external ear canal in standing sedated horses and to create a grading of debris and the occurrence of abnormalities in clinically healthy horses. Local blockage of the great and internal auricular nerves was performed after caudal palpation at the base of the ear and ultrasonographic assessment of the styloid process of the auricle as a reference point for the needle placement. The otoscopic examination was accomplished with two flexible video endoscopes with 2- and 7-mm tip diameters. The depth of the styloid process varied ultrasonographically from 2.08 to 2.73 cm on the left side and from 2.04 to 2.76 cm on the right side. Local anesthesia was successful in all sedated horses, without any long-term complications. The grading of endoscopic appearance of the skin, epithelium, and ceruminous and cell debris in the cartilaginous and osseous part including tympanic membrane of the equine external ear canal ranged from I to III. Abnormalities like osteoma, granuloma, hemorrhagic or erythematous areas, and narrowing of the osseous part of the external ear canal due to stenosis (exostosis) were seen in 10 of 23 horses. The tympanic membrane was visualized in 20 of 23 horses. Local blockage of the great and internal auricular nerves was found to be a reliable method for equine ear anesthesia.     

Pharmacokinetics and Effects of Alkalization During Oral and Intravenous Administration of Naproxen in Horses

The use of suitable therapeutic protocols is particularly important when extra-label drugs are used or when physiological parameters are modified, as in the case of the administration of alkaline substances to racehorses. The pharmacokinetics of naproxen (NAP), after both intravenous (iv) and oral administration of 10 mg/kg body weight (BW), was investigated in horses under normal metabolic conditions and in horses whose conditions were modified by the iv administration of 250 mg/kg BW of sodium bicarbonate (NaHCO₃). The hypothesis that blood and consequent urinary alkalization could modify NAP pharmacokinetics was evaluated. Drug quantification was performed on serum and urine using High Performance Liquid Chromatography (HPLC) with ultraviolet-visible detection. Results were also integrated with cycloxygenase (COX)-inhibition published data to suggest an appropriate schedule for NAP dosage in horses. After iv administration, NAP was rapidly distributed (t_1/2α: 0.71 ± 0.43 iv NaHCO₃ and 0.55 ± 0.62 hours No NaHCO₃), whereas its elimination was quite slow (t_1/2β: 6.74 ± 0.41 hours), particularly in iv NaHCO₃ animals (t_1/2β: 8.95 ± 1.37 hours). After oral treatments, NAP was more rapidly absorbed and elimination was slower in iv NaHCO₃ animals (t_1/2λ_z: 17.50 ± 6.66 vs. 7.17 ± 0.91 hours). The oral bioavailability of NAP was approximately 87% and 77% in No NaHCO₃ and iv NaHCO₃, respectively. Urinary excretion of the drug as a parent compound was low. The alkalization procedure did not anticipate the elimination of the acidic drug as expected, but it also influenced the absorption of the drug that was administered orally. The dosage scheme of 10 mg/kg BW iv or orally seems to be appropriate to produce an anti-inflammatory effect for 12 to 24 hours.     

Long-term Outcome of Standing Medial Patellar Ligament Splitting to Manage Horses Exhibiting Delayed Patellar Release: 64 Horses

A standing surgical technique for splitting the medial patellar ligament is described, and the long-term (average 4.5-years) efficacy of the procedure in horses exhibiting delayed patellar release is reported. Medical records of 64 horses that underwent a standing medial patellar ligament splitting surgery performed to treat delayed patellar release were analyzed retrospectively. Horses were sedated in standing stocks. A number 15 scalpel blade was used to percutaneously split the medial patellar ligament from just proximal to its insertion on the tibial tuberosity to its attachment on the parapatellar fibrocartilage, with the goal of inducing a localized desmitis and subsequent thickening of the ligament. Aftercare consisted of oral antibiotics, 14 days stall rest with hand walking, light exercise for 14 days, and full work at 4 weeks. Follow-up information was obtained through telephone calls to owners and/or clinical evaluation by a veterinarian. Results showed that 89% of horses benefitted from the procedure, with complete resolution in 58% of horses and improvement in 31% of horses. A total of 73% of horses were able to perform at the desired level following the procedure; 63% of horses showed signs of improvement or resolution within 30 to 60 days. Two horses had complications following the procedure: 1 horse had an incisional infection, and 1 had a medial patellar ligament rupture. This study shows that standing medial patellar ligament splitting is a successful, long-term surgical option for treatment of delayed patellar release. The procedure has few complications and allows rapid return to desired performance.